Skip to main content

Incannex welcomes world-leading psychedelics experts to advisory board

ⓘ This article is third-party content and does not represent the views of this site. We make no guarantees regarding its accuracy or completeness.

Incannex Healthcare Ltd (ASX:IHL, NASDAQ: IXHL) director Peter Widdows tells Proactive the company has appointed three world-renowned psychedelic therapy and science experts to its Clarion Clinics Group Advisory Board. The Clarion Clinics Groups Pty Ltd is a collaborative venture between Incannex and three leading Australian psychedelics experts - Dr Paul Liknaitzky, Professor Suresh Sundram and Sean O’Carroll.

Contact Details

Proactive Investors

Jonathan Jackson

+61 413 713 744

Jonathan@proactiveinvestors.com

Report this content

If you believe this article contains misleading, harmful, or spam content, please let us know.

Report this article

Recent Quotes

View More
Symbol Price Change (%)
AMZN  262.24
-4.08 (-1.53%)
AAPL  309.22
+0.40 (0.13%)
AMD  497.35
+29.84 (6.38%)
BAC  51.94
+0.14 (0.26%)
GOOG  382.37
+2.99 (0.79%)
META  609.31
-0.95 (-0.16%)
MSFT  413.29
-5.28 (-1.26%)
NVDA  213.46
-1.87 (-0.87%)
ORCL  190.90
-1.18 (-0.61%)
TSLA  431.46
+5.45 (1.28%)
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.